» Articles » PMID: 18948740

Delphinidin, a Dietary Anthocyanidin in Pigmented Fruits and Vegetables: a New Weapon to Blunt Prostate Cancer Growth

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2008 Oct 25
PMID 18948740
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

In a recent publication, we have shown that delphinidin, an anthocyanidin induces apoptosis and cell cycle arrest in highly metastatic human prostate cancer (PCa) PC3 cells. Extending these studies, we provide additional evidence that delphinidin induces apoptosis and cell cycle arrest in androgen refractory human PCa 22Rnu1 cells and that these effects are concomitant with inhibition of NFkappaB. We observed that delphinidin treatment to 22Rnu1 cells resulted in a dose-dependent (i) G(2)/M phase cell cycle arrest, (ii) induction of apoptosis (iii) and inhibition of NFkappaB signaling. The induction of apoptosis by delphinidin was mediated via activation of caspases since a general caspase inhibitor Z-VAD-FMK significantly reversed this effect. Delphinidin treatment to cells resulted in a dose-dependent decrease in (i) phosphorylation of IKKgamma (NEMO), (ii) phosphorylation of NFkappaB inhibitory protein IkappaBalpha, (iii) phosphorylation of NFkappaB/p65 at Ser(536) and NFkappaB/p50 at Ser529, (iv) NFkappaB/p65 nuclear translocation, and (v) NFkappaB DNA binding activity. Taken together, our data show that delphinidin induces apoptosis of both androgen independent and androgen refractory human PCa cells via activation of caspases and in addition, this effect might be due to inhibition of NFkappaB signaling. We suggest that delphinidin could be developed as a novel agent against PCa.

Citing Articles

Plant bioactive compounds driven microRNAs (miRNAs): A potential source and novel strategy targeting gene and cancer therapeutics.

Sumaira S, Vijayarathna S, Hemagirri M, Adnan M, Hassan M, Patel M Noncoding RNA Res. 2024; 9(4):1140-1158.

PMID: 39022680 PMC: 11250886. DOI: 10.1016/j.ncrna.2024.06.003.


Phytochemicals in Inhibition of Prostate Cancer: Evidence from Molecular Mechanisms Studies.

Hao Q, Wu Y, Vadgama J, Wang P Biomolecules. 2022; 12(9).

PMID: 36139145 PMC: 9496067. DOI: 10.3390/biom12091306.


Pharmacological Small Molecules against Prostate Cancer by Enhancing Function of Death Receptor 5.

Gan X, Liu Y, Wang X Pharmaceuticals (Basel). 2022; 15(8).

PMID: 36015177 PMC: 9413322. DOI: 10.3390/ph15081029.


Chemopreventive Potential of Dietary Nanonutraceuticals for Prostate Cancer: An Extensive Review.

Chopra H, Bibi S, Goyal R, Gautam R, Trivedi R, Upadhyay T Front Oncol. 2022; 12:925379.

PMID: 35903701 PMC: 9315356. DOI: 10.3389/fonc.2022.925379.


The Promising Therapeutic and Preventive Properties of Anthocyanidins/Anthocyanins on Prostate Cancer.

Mottaghipisheh J, Doustimotlagh A, Irajie C, Tanideh N, Barzegar A, Iraji A Cells. 2022; 11(7).

PMID: 35406634 PMC: 8997497. DOI: 10.3390/cells11071070.


References
1.
Malik A, Afaq F, Sarfaraz S, Adhami V, Syed D, Mukhtar H . Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci U S A. 2005; 102(41):14813-8. PMC: 1253570. DOI: 10.1073/pnas.0505870102. View

2.
Owa T, Yoshino H, Yoshimatsu K, Nagasu T . Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents. Curr Med Chem. 2001; 8(12):1487-503. DOI: 10.2174/0929867013371996. View

3.
McDonald 3rd E, El-Deiry W . Cell cycle control as a basis for cancer drug development (Review). Int J Oncol. 2000; 16(5):871-86. View

4.
Karin M, Ben-Neriah Y . Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol. 2000; 18:621-63. DOI: 10.1146/annurev.immunol.18.1.621. View

5.
Hou D, Fujii M, Terahara N, Yoshimoto M . Molecular Mechanisms Behind the Chemopreventive Effects of Anthocyanidins. J Biomed Biotechnol. 2004; 2004(5):321-325. PMC: 1082887. DOI: 10.1155/S1110724304403040. View